Eli Lilly
Stock
Stock
ISIN: US5324571083
Ticker: LLY
US5324571083
LLY
Price
Price
CHART BY
Historical dividends and forecast
The next dividend will be paid on 10.03.2025
$1.669
CHART BY
Frequently asked questions
What is Eli Lilly's market capitalization?
The market capitalization of Eli Lilly is $827.87B. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.
What is Eli Lilly's Price-to-Earnings (P/E) ratio?
The Price-to-Earnings (P/E) ratio (TTM) for Eli Lilly is 74.54. This ratio helps investors assess whether a stock is overvalued or undervalued compared to its earnings.
What is the Earnings Per Share (EPS) for Eli Lilly?
Eli Lilly's Earnings Per Share (EPS) over the trailing twelve months (TTM) is $11.72. EPS indicates the company's profitability on a per-share basis.
What are the analyst ratings and target price for Eli Lilly's stock?
Currently, 29 analysts cover Eli Lilly's stock, with a consensus target price of $1,023.03. Analyst ratings provide insights into the stock's expected performance.
What is Eli Lilly's revenue over the trailing twelve months?
Over the trailing twelve months, Eli Lilly reported a revenue of $45.04B.
Is Eli Lilly paying dividends?
Yes, Eli Lilly is paying dividends. The next payment is scheduled for 10.03.2025, with an expected amount of .
What is the free float of Eli Lilly's shares?
The free float of Eli Lilly is 849.52M. Free float refers to the number of shares available for public trading, excluding restricted shares.
Financials
- Market Cap
- $827.87B
- EPS (TTM)
- $11.72
- Free Float
- 849.52M
- P/E ratio (TTM)
- 74.54
- Revenue (TTM)
- $45.04B
Pricing
- 1D span
- $871.10$894.86
- 52W span
- $712.06$972.24
Analyst Ratings
The price target is $1,023.03 and the stock is covered by 29 analysts.
Buy
23
Hold
5
Sell
1
Information
Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products consist of diabetes, oncology, immunology, neuroscience, and other products and therapies. The company was founded by Eli Lilly in May 1876 and is headquartered in Indianapolis, IN.
- Industries
- Major Pharmaceuticals
- Sector
- Health Care
Identifier
- ISIN
- US5324571083
- Primary Ticker
- LLY
Knockouts
Finance data from FactSet